These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 28697102

  • 1. Secnidazole Treatment of Bacterial Vaginosis: A Randomized Controlled Trial.
    Hillier SL, Nyirjesy P, Waldbaum AS, Schwebke JR, Morgan FG, Adetoro NA, Braun CJ.
    Obstet Gynecol; 2017 Aug; 130(2):379-386. PubMed ID: 28697102
    [Abstract] [Full Text] [Related]

  • 2. A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis.
    Schwebke JR, Morgan FG, Koltun W, Nyirjesy P.
    Am J Obstet Gynecol; 2017 Dec; 217(6):678.e1-678.e9. PubMed ID: 28867602
    [Abstract] [Full Text] [Related]

  • 3. An Integrated Efficacy and Safety Analysis of Single-Dose Secnidazole 2 g in the Treatment of Bacterial Vaginosis.
    Pentikis H, Adetoro N, Tipping D, Levy S.
    Reprod Sci; 2020 Feb; 27(2):523-528. PubMed ID: 32046418
    [Abstract] [Full Text] [Related]

  • 4. Treatment of bacterial vaginosis: a multicenter, double-blind, double-dummy, randomised phase III study comparing secnidazole and metronidazole.
    Bohbot JM, Vicaut E, Fagnen D, Brauman M.
    Infect Dis Obstet Gynecol; 2010 Feb; 2010():. PubMed ID: 20885970
    [Abstract] [Full Text] [Related]

  • 5. Secnidazole for treatment of bacterial vaginosis: a systematic review.
    Abd El Aziz MA, Sharifipour F, Abedi P, Jahanfar S, Judge HM.
    BMC Womens Health; 2019 Oct 21; 19(1):121. PubMed ID: 31638955
    [Abstract] [Full Text] [Related]

  • 6. Low-dose secnidazole in the treatment of bacterial vaginosis.
    Núñez JT, Gómez G.
    Int J Gynaecol Obstet; 2005 Mar 21; 88(3):281-5. PubMed ID: 15733882
    [Abstract] [Full Text] [Related]

  • 7. Two phase 3, double-blind, placebo-controlled studies of the efficacy and safety of Astodrimer 1% Gel for the treatment of bacterial vaginosis.
    Chavoustie SE, Carter BA, Waldbaum AS, Donders GGG, Peters KH, Schwebke JR, Paull JRA, Price CF, Castellarnau A, McCloud P, Kinghorn GR.
    Eur J Obstet Gynecol Reprod Biol; 2020 Feb 21; 245():13-18. PubMed ID: 31812702
    [Abstract] [Full Text] [Related]

  • 8. A Phase 3, Multicenter, Prospective, Open-Label Study to Evaluate the Safety of a Single Dose of Secnidazole 2 g for the Treatment of Women and Postmenarchal Adolescent Girls with Bacterial Vaginosis.
    Chavoustie SE, Gersten JK, Samuel MJ, Schwebke JR.
    J Womens Health (Larchmt); 2018 Apr 21; 27(4):492-497. PubMed ID: 29323627
    [Abstract] [Full Text] [Related]

  • 9. Treatment for Symptomatic Bacterial Vaginosis: ARandomized Controlled Trial.
    Tariq N, Basharat A, Khan DH, Fahim A, Khan MH.
    J Coll Physicians Surg Pak; 2017 Nov 21; 27(11):686-689. PubMed ID: 29132478
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and Safety of Single Oral Dosing of Secnidazole for Trichomoniasis in Women: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Delayed-Treatment Study.
    Muzny CA, Schwebke JR, Nyirjesy P, Kaufman G, Mena LA, Lazenby GB, Van Gerwen OT, Graves KJ, Arbuckle J, Carter BA, McMahon CP, Eder S, Shaw J, Pandey B, Chavoustie SE.
    Clin Infect Dis; 2021 Sep 15; 73(6):e1282-e1289. PubMed ID: 33768237
    [Abstract] [Full Text] [Related]

  • 11. Treatment of bacterial vaginosis with oral or vaginal ornidazole, secnidazole and metronidazole.
    Saraçoğlu F, Göl K, Sahin I, Türkkani B, Atalay C, Oztopçu C.
    Int J Gynaecol Obstet; 1998 Jul 15; 62(1):59-61. PubMed ID: 9722127
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of single dose of oral secnidazole 2 g in treatment of bacterial vaginosis: A systematic review and meta-analysis.
    Elghazaly SM, Hamam KM, Badawy MM, Yakoub Agha NA, Samy A, Abbas AM.
    Eur J Obstet Gynecol Reprod Biol; 2019 Jul 15; 238():125-131. PubMed ID: 31129560
    [Abstract] [Full Text] [Related]

  • 13. A phase 2, double-blind, multicenter, randomized, placebo-controlled, dose‑ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis.
    Waldbaum AS, Schwebke JR, Paull JRA, Price CF, Edmondson SR, Castellarnau A, McCloud P, Kinghorn GR.
    PLoS One; 2020 Jul 15; 15(5):e0232394. PubMed ID: 32365097
    [Abstract] [Full Text] [Related]

  • 14. Single-Dose, Bioadhesive Clindamycin 2% Gel for Bacterial Vaginosis: A Randomized Controlled Trial.
    Mauck C, Hillier SL, Gendreau J, Dart C, Chavoustie S, Sorkin-Wells V, Nicholson-Uhl C, Perez B, Jacobs M, Zack N, Friend D.
    Obstet Gynecol; 2022 Jun 01; 139(6):1092-1102. PubMed ID: 35675606
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness of two tinidazole regimens in treatment of bacterial vaginosis: a randomized controlled trial.
    Livengood CH, Ferris DG, Wiesenfeld HC, Hillier SL, Soper DE, Nyirjesy P, Marrazzo J, Chatwani A, Fine P, Sobel J, Taylor SN, Wood L, Kanalas JJ.
    Obstet Gynecol; 2007 Aug 01; 110(2 Pt 1):302-9. PubMed ID: 17666604
    [Abstract] [Full Text] [Related]

  • 16. BASIC study: is intravaginal boric acid non-inferior to metronidazole in symptomatic bacterial vaginosis? Study protocol for a randomized controlled trial.
    Zeron Mullins M, Trouton KM.
    Trials; 2015 Jul 26; 16():315. PubMed ID: 26210791
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of single-dose oral secnidazole for the treatment of trichomoniasis in women co-infected with trichomoniasis and bacterial vaginosis: a post hoc subgroup analysis of phase 3 clinical trial data.
    Muzny CA, Van Gerwen OT, Kaufman G, Chavoustie S.
    BMJ Open; 2023 Aug 07; 13(8):e072071. PubMed ID: 37550019
    [Abstract] [Full Text] [Related]

  • 18. Secnidazole: next-generation antimicrobial agent for bacterial vaginosis treatment.
    Nyirjesy P, Schwebke JR.
    Future Microbiol; 2018 Apr 07; 13():507-524. PubMed ID: 29327947
    [Abstract] [Full Text] [Related]

  • 19. A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of Metronidazole Vaginal Gel 1.3% in the Treatment of Bacterial Vaginosis.
    Schwebke JR, Marrazzo J, Beelen AP, Sobel JD.
    Sex Transm Dis; 2015 Jul 07; 42(7):376-81. PubMed ID: 26222750
    [Abstract] [Full Text] [Related]

  • 20. Secnidazole. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic use in the management of protozoal infections and bacterial vaginosis.
    Gillis JC, Wiseman LR.
    Drugs; 1996 Apr 07; 51(4):621-38. PubMed ID: 8706597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.